[144] Endava plc SEC Filing

Rhea-AI Filing Summary

Endava (DAVA) shareholder filed a Form 144 to sell up to 7,494 common shares with an aggregate market value of $52,917, on or about November 13, 2025, on the NYSE through Stifel Nicolaus & Company Inc.

The filing lists 56,208,871 shares outstanding as context. The shares to be sold were acquired via restricted stock units on May 28, 2025 (amount acquired: 7,396 shares). In the prior three months, Alastair Lukies reported a sale of 3,504 shares on October 31, 2025 for $32,335.

Insights

Securities law analyst

Routine Form 144 notice for a planned small share sale.

This filing is a notice of a proposed sale of restricted or control securities under Rule 144. It lists a plan to sell up to 7,494 shares of Endava common stock with an $52,917 aggregate market value, using the NYSE and broker Stifel. Such notices are administrative and do not alter company operations.

The shares were originally acquired via restricted stock units on May 28, 2025. The document also notes a prior sale by Alastair Lukies of 3,504 shares on October 31, 2025 for $32,335. Actual sale activity depends on market conditions and holder decisions.

For context, shares outstanding were 56,208,871. This is a baseline figure. Subsequent filings may provide execution details if sales occur.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	7494	52917.00	56208871	11/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/28/2025	Restricted Stock Units	Issuer			7396	10/31/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alastair Lukies 125 Old Broad Street London X0 EC2N1AR	Common Stock	10/31/2025	3504	32335.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)